The use of state-dependent modulation of spinal reflexes as a tool to investigate the organization of spinal interneurons

Exp Brain Res. 1999 Oct;128(3):263-77. doi: 10.1007/s002210050847.

Abstract

This review examines the proposition that state-dependent modulation of transmission through spinal reflex pathways can be used as an investigative tool to reveal details about the organization of spinal interneurons into functional circuits. The first set of examples includes the use of spinal and supraspinal lesions, as well as the administration of the drug l-dihydroxyphenylalanine (l-DOPA), to produce different, relatively stable "states" of the central nervous system (CNS), revealing previously unsuspected spinal pathways activated by the flexor reflex afferents (FRA). The second set of examples deals with the use of fictive locomotion and scratching to investigate the organization of oligosynaptic excitatory and inhibitory reflex pathways from cutaneous and muscle afferents. As in the first set of examples, several hitherto unknown reflex pathways have been found only during the flexion or extension phases of rhythmic locomotion, which are regarded as different CNS states. Differences in the patterns of control can be used to infer the existence of distinct sets of reflex pathway interneurons that have remarkably precise input/output relations.

Publication types

  • Review

MeSH terms

  • Afferent Pathways / drug effects
  • Afferent Pathways / physiology
  • Animals
  • Decerebrate State
  • Dopamine Agents / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / physiology*
  • Humans
  • Interneurons / drug effects
  • Interneurons / physiology*
  • Levodopa / pharmacology
  • Locomotion / physiology
  • Motor Neurons / drug effects
  • Motor Neurons / physiology*
  • Neural Pathways / drug effects
  • Neural Pathways / physiology
  • Reflex / drug effects
  • Reflex / physiology*
  • Spinal Cord / drug effects
  • Spinal Cord / physiology*

Substances

  • Dopamine Agents
  • Levodopa